Embedding penicillinde-labelling in the AMU: a feasibility and safety pilot study with exploratory economic and environmental analysis

Original Articles, Volume 24, Issue 3, Pages 109 – 148 (2025)

Background: Penicillin allergy labels affect 6-10% of the UK population, yet over 95% are inaccurate. These labels drive unnecessary broad-spectrum antibiotic use, antimicrobial resistance, healthcare costs, adverse patient outcomes and carbon emissions.Methods: This pilot study embedded a penicillin allergy de-labelling (PADL) clinic within an Acute Medical Unit, using a direct oral amoxicillin challenge for patients...

Please subscribe to see more.
Subscribe
Already a member? Log in here

Embedding penicillinde-labelling in the AMU: a feasibility and safety pilot study with exploratory economic and environmental analysis Read More